[1]Patent:US2012/77806,2012,A1.Locationinpatent:Page/Pagecolumn29;32
[1]Patent:US2012/77806,2012,A1.Locationinpatent:Page/Pagecolumn29;32
[1]Patent:WO2015/183987,2015,A1.Locationinpatent:Paragraph00349
[1]ChemicalCommunications,2020,vol.56,p.2929-2932
[2]Patent:WO2015/183987,2015,A1.Locationinpatent:Paragraph00348
[1]ChemicalCommunications,2020,vol.56,p.2929-2932
Title: Vialinin A is a ubiquitin-specific peptidase inhibitor.
Journal: Bioorganic & medicinal chemistry letters 20130801
Title: A novel small molecule deubiquitinase inhibitor blocks Jak2 signaling through Jak2 ubiquitination.
Journal: Cellular signalling 20111201
Title: Tyrphostin-like compounds with ubiquitin modulatory activity as possible therapeutic agents for multiple myeloma.
Journal: Bioorganic & medicinal chemistry 20111201
Title: Bcr-Abl ubiquitination and Usp9x inhibition block kinase signaling and promote CML cell apoptosis.
Journal: Blood 20110317
Title: Degrasyn potentiates the antitumor effects of bortezomib in mantle cell lymphoma cells in vitro and in vivo: therapeutic implications.
Journal: Molecular cancer therapeutics 20100701
Title: Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells.
Journal: Blood 20070415
Title: Bartholomeusz GA, et al. Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells. Blood. 2007 Apr 15;109(8):3470-8.